Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996. His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 61 countries and has published 472 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.
Sandro Esteves, MD., Ph.D. is a board-certified urologist and consultant in assisted reproduction with over 25 years of clinical experience in all areas of reproductive medicine, with specialization in male reproduction.
He is listed by Expertscape among the top three world experts in the areas of male infertility, azoospermia, varicocele, and sperm retrieval techniques. Sandro has been also included in the list of the world’s most influential scientists.
He is the Founder and Medical Director of the ANDROFERT Andrology & Human Reproduction Clinic, in Campinas, Brazil. Dr. Esteves established the first Brazilian Fertility Clinic with a primary focus on male infertility, as well as the very first to introduce quality management as per the ISO 9001 standards and IVF cleanroom technology (ISO 14644-1).
Sandro is also a Collaborating Professor of Urology at the University of Campinas (UNICAMP, Brazil) and Honorary Professor of Reproductive Medicine at Aarhus University (Denmark). Dr. Esteves received his Master’s in Surgery from the University of Campinas Medical School and his Ph.D. in Urology from the Federal University of São Paulo Medical School. His post-doctoral training was at the American Center for Reproductive Medicine at the Cleveland Clinic in the United States. He has received many research grants and awards from national and international societies.
Prof. Esteves is the author of 10 textbooks in the fields of infertility and reproductive medicine. He was also the co-editor of several Journal Supplements and has published over 400 hundred scientific papers in journals like Lancet, Nature, Human Reproduction Update, Human Reproduction, Fertility and Sterility, etc. His current Hirsch index (h-index) is 63 while his citation count is over 12K. He is a member of ‘Faculty Opinions’ in the area of reproductive endocrinology & infertility. Dr. Esteves is Associate Editor of Frontiers in Endocrinology (Reproduction), Andrology, International Brazilian Journal of Urology, Regional Editor of the Société Internationale d’Urologie Journal, an editorial board member of Nature Reviews Urology, and a dozen of other peer-reviewed scientific journals. He is also a co-founder of the POSEIDON group and currently serves as a Chair of the Male Infertility Section of the WHO Infertility Guidelines Development Group.
Dr. Esteves is a very much requested speaker and presents over 50 lectures annually. He also regularly conducts infertility workshops, provides consulting services in the area of quality management for ART Clinics,
Gurkan Bozdag completed his Reproductive Medicine and Infertility Certification training at Hacettepe University. He gave postgraduate and doctorate courses in Reproductive Medicine and Infertility. He has more than 110 publications in international peer-reviewed journals, and some of his studies were awarded in the best poster category by The American Society of Reproductive Medicine. He took part in the editorial boards of various international and national scientific journals, including Human Reproduction, Clinical and Experimental Obstetrics & Gynecology, Frontiers in Endocrinology.
He took part in the regulatory boards of national and international symposiums and congresses in the field of reproductive medicine and in vitro fertilization. He also acted as the National Representative of Turkey in ESHRE (2020 – 2022) and as a co-author in the Guideline Development Group of Add-ons
He is currently the 2nd President of the Society for Reproductive Endocrinology and Infertility (TSRM) and is a member of the board of directors of national professional associations. From Jan-2022, he has been the Director of REI clinic in Koc University. He was also assigned as one of the executive member of ESHRE in June 2023.
Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. Moreover, he is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient, and a past board member of the ESHRE SIG Endocrinology Group. He is in the Elsevier, Stanford global list of 2% top scientists, and he authored and co-authored 250 + articles (H-index 67, Google Scholar) in international peer reviewed journals as well as chapters in textbooks and the Danish guidelines for OHSS prevention. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.
Professor Hugues was the head of Reproductive Medicine Unit at University Paris XIII.
He trained in Endocrinology and Gynaecology before being appointed as Professor of Reproductive Medicine and Development.
He succeeded in PhD in Biology of Reproduction at the University Paris XI
He was a member of many international scientific societies (ESHRE – ASRM – SGI)
His interest for the control of ovarian function and ovulation induction led him to conduct several clinical trials and to publish more than hundred articles in peer reviews.
Matheus Roque is the Scientific Director at Origen – Center for Reproductive Medicine, Brazil. Dr. Roque obtained his degree in Medicine in 2003 at the Marilia Medical School, Mar lia, Brazil and he is currently working towards his PhD in Women’s Health at the Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. He obtained his Masters in Reproductive Medicine in 2012 at the Universitat Aut noma de Barcelona, Barcelona, Spain, and completed a Fellowship in Human Reproduction during 2009 –2010 at the Universidade Federal de S o Paulo, S o Paulo, Brazil. Dr. Roque has authored many scientific articles and book chapters, and has served as a reviewer for several indexed medical journals. He has been an active participant in many international and national congresses in reproductive medicine and urology, presenting abstracts and lectures. Dr. Roque has participated in the 2015 European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting as an Invited Speaker delivering the lecture Towards a “freeze-all” policy. Fertility and Sterility has recently acknowledged Dr. Roque in recognition of his contribution to the quality of the journal. Moreover, one of his papers featured in the top 5 most highly cited papers published in Fertility and Sterility during 2014 and 2015. He has been recently awarded with the GFI – Grant for Fertility Innovation, with the project entitled “Pharmacogenetic algorithm for individualized Controlled Ovarian Stimulation (iCOS)”. He is currently a member of ESHRE, the American Society for Reproductive Medicine, the Brazilian Society for Assisted Reproduction, and the Brazilian Society of Urology.
